Glucose metabolism in lean patients with mild type 2 diabetes mellitus: Evidence for insulin-sensitive and insulin-resistant variants

Metabolism: Clinical and Experimental

Volumn 51, Issue 8, 2002, Pages 1047-1052

  García Estévez, Daniel A ^a,b   Araújo Vilar, David ^a,b   Saavedra González, Ángeles ^a,b   Fietras Janeiro, Gloria ^a,b   Cabezas Cerrato, José ^a,b  

^a University Hospital of Santiago de Compostela   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ARTICLE; BODY MASS; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENETIC HETEROGENEITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0036344439     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.33340     Document Type: Article

References (46)

1. The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM
2. Glucose metabolism in obesity and type 2 diabetes
3. Insulin-sensitive and insulin-resistant variants in NIDDM
4. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects
5. Pathogenic factors responsible for glucose intolerance in patients with NIDDM
6. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients
7. Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive?
8. Normal hepatic insulin sensitivity in lean, mild non-insulin-dependent diabetic patients
9. Clinical perspective: Insulin resistance is not necessarily an essential component of type 2 diabetes
10. Contribution of obesity to insulin resistance in non-insulin-dependent diabetes mellitus
11. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes
12. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus
13. Insulin action, diabetogenes, and the cause of type II diabetes
14. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus
15. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM patients
16. Insulin sensitivity, glucose effectiveness, and insulin secretion in non-diabetic offspring of patients with non-insulin-dependent diabetes mellitus: A cross-sectional study
17. Impaired pulsatil secretion of insulin in relatives of patients with non-insulin dependent diabetes mellitus
18. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM
19. Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: Evidence of early β-cell dysfunction
20. Quantitative estimation of insulin sensitivity
21. Toward physiological understanding of glucose tolerance: Minimal model approach
22. Role of glucose effectiveness in the determination of glucose tolerance
23. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects
24. Report of the Expert Committee on the diagnosis and classification of Diabetes
25. Insulin sensitivity in non-insulin-dependent diabetes mellitus and obesity using the minimal model approach. Importance of early insulin secretion on carbohydrate tolerance
26. Non-insulin-mediated glucose uptake in several insulin resistant states in the post-absorptive period
27. Ethical principles for medical research involving human subjects
28. Minimal model of glucose metabolism: Modified equations and its application in the study of insulin sensitivity in obese subjects
29. Insulin sensitivity, glucose effectiveness and B-cell function in obese males with essential hypertension: Investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril)
30. Reliability of error estimates from minimal model: Implications for measurements in physiological studies
31. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function
32. Rates of non insulin-mediated glucose uptake are elevated in type II diabetic subjects
33. Direct evidence for a stimulatory effect of hyperglycaemia per se on peripheral glucose disposal in type II diabetes
34. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects
35. Both a reduced acute insulin response to glucose and lower glucose effectiveness are responsible for the worsening of intravenous glucose tolerance in healthy subjects independently of the degree of obesity
36. Duration of obesity increases the incidence of NIDDM
37. Evolution from obesity to diabetes
38. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus
39. Insulin sensitivity, glucose effectiveness and body fat distribution patterns in non-diabetic offspring of patients with NIDDM
40. Increased glucose effectiveness in normoglycaemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism
41. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance
42. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans
43. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes
44. Insulin secretion, insulin action and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus
45. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands
46. Increased insulin sensitivity and decreased insulin secretion in offspring of insulin-sensitive type 2 diabetic patients